What companies are IPHA's competitors?

Innate Pharma S.A. (IPHA)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does IPHA compare to its peers?

The peer comparison table on this page shows Innate Pharma S.A. (IPHA) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does IPHA operate in?

Innate Pharma S.A. (IPHA) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

IPHA

Innate Pharma S.A.

NASDAQ·Biotechnology · Healthcare

$2.22$0.01−0.45%

After hours·$2.22+0.00%

Market cap$208.47M·Market closed·Aug 28 8:00 PM UTC

Frequently Asked Questions About IPHA

What companies are IPHA's competitors?: Innate Pharma S.A. (IPHA)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does IPHA compare to its peers?: The peer comparison table on this page shows Innate Pharma S.A. (IPHA) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does IPHA operate in?: Innate Pharma S.A. (IPHA) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

IPHA

Innate Pharma S.A.

NASDAQ·Biotechnology · Healthcare

$2.22$0.01−0.45%

After hours·$2.22+0.00%

Market cap$208.47M·Market closed·Aug 28 8:00 PM UTC

Peers


NVCT	Nuvectis Pharma, Inc.	$23.67	$628.1M
CYBN	Cybin Inc.	$8.28	$413.0M
CGEN	Compugen Ltd.	$2.60	$245.8M
CRBP	Corbus Pharmaceuticals Holdings, Inc.	$10.91	$202.1M
MOLN	Molecular Partners AG	$4.50	$168.8M
MIST	Milestone Pharmaceuticals Inc.	$1.16	$144.4M
CRDF	Cardiff Oncology, Inc.	$0.94	$72.4M
RANI	Rani Therapeutics Holdings, Inc.	$0.84	$54.9M
ELTX	Elicio Therapeutics, Inc.	$2.84	$54.1M
APLT	Applied Therapeutics, Inc.	$0.10	$14.9M

Frequently Asked Questions About IPHA

What companies are IPHA's competitors?: Innate Pharma S.A. (IPHA)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does IPHA compare to its peers?: The peer comparison table on this page shows Innate Pharma S.A. (IPHA) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does IPHA operate in?: Innate Pharma S.A. (IPHA) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.